levofloxacin has been researched along with Soft Tissue Infections in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Erber, J; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Tschaikowsky, T; Weidlich, S | 1 |
| Chen, G; Dong, C; Dong, Y; Fang, Y; Tao, X; Wu, S; Xu, K; Yu, Z; Zhang, L; Zhou, X; Zhu, F | 1 |
| Busse, D; Huisinga, W; Ilia, L; Kloft, C; Michelet, R; Schaeftlein, A; Solms, A; Zeitlinger, M | 1 |
| Cui, J; Ni, W; Song, X | 1 |
| Babarina, MB; Sokolova, VI; Sychev, DA; Zaikov, DA | 1 |
| Blatun, LA; Terekhova, RP | 1 |
| Bellmann, R; Dehghanyar, P; Joukhadar, C; Kuchling, G; Mayer, BX; Minar, E; Müller, M; Zeitlinger, M | 1 |
| Blatun, LA; Iakovlev, VP; Svetukhin, AM; Ukhin, SA | 1 |
| Finegold, SM; Molitoris, D; Molitoris, E; Wexler, HM | 1 |
| Lamb, HM; Langtry, HD | 1 |
| Breen, JD; Brown, MJ; Champlin, J; Jones, TM; Miskin, BM; Tarshis, GA; Wingert, KJ | 1 |
3 review(s) available for levofloxacin and Soft Tissue Infections
| Article | Year |
|---|---|
[Levofloxacin in complex therapy of patients with skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Humans; Levofloxacin; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 2008 |
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastrointestinal Diseases; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Skin Diseases; Skin Diseases, Bacterial; Soft Tissue Infections; Urea | 2004 |
Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
Topics: Animals; Anti-Infective Agents; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections | 1998 |
1 trial(s) available for levofloxacin and Soft Tissue Infections
| Article | Year |
|---|---|
Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcus aureus; Treatment Outcome | 2001 |
8 other study(ies) available for levofloxacin and Soft Tissue Infections
| Article | Year |
|---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
Topics: Amikacin; Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Macrolides; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Soft Tissue Injuries; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2020 |
Vogesella perlucida-induced bacteremia in an advanced-age patient: first case report.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Betaproteobacteria; Female; Humans; Levofloxacin; RNA, Ribosomal, 16S; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2020 |
Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Height; Body Weight; Environmental Exposure; Humans; Levofloxacin; Male; Microdialysis; Middle Aged; Models, Statistical; Soft Tissue Infections | 2021 |
Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Levofloxacin; Microbial Sensitivity Tests; Rabbits; Soft Tissue Infections | 2014 |
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions].
Topics: Adult; Anti-Bacterial Agents; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
Tissue pharmacokinetics of levofloxacin in human soft tissue infections.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Microdialysis; Middle Aged; Ofloxacin; Soft Tissue Infections; Tissue Distribution | 2004 |
In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Colony Count, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Skin Diseases, Infectious; Soft Tissue Infections | 1998 |